---
title: "688016.SH (688016.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688016.SH/news.md"
symbol: "688016.SH"
name: "688016.SH"
parent: "https://longbridge.com/en/quote/688016.SH.md"
datetime: "2026-05-19T23:29:26.543Z"
locales:
  - [en](https://longbridge.com/en/quote/688016.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688016.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688016.SH/news.md)
---

# 688016.SH (688016.SH) — Related News

### [Directly hitting the Endovastec shareholder meeting: early discussions, on-site exhibition tour, executives surrounded and questioned about "the way out"](https://longbridge.com/en/news/286588031.md)
*2026-05-15T15:27:19.000Z*
> Endovastec held its 2025 annual shareholder meeting on May 13 to discuss future products and business transformation. In

### [The sixth batch of national procurement for consumables will be intensively implemented in May](https://longbridge.com/en/news/285501988.md)
*2026-05-07T07:20:14.000Z*
> The sixth batch of national organized centralized procurement of high-value medical consumables has entered the implemen

### [The National Medical Products Administration has approved multiple innovative medical devices for market launch](https://longbridge.com/en/news/284751762.md)
*2026-04-30T10:57:57.000Z*
> Recently, the National Medical Products Administration approved the registration application for intracardiac ultrasound

### [MICROPORT's subsidiary Endovastec earned 155 million RMB in the first quarter, an increase of 19.4%](https://longbridge.com/en/news/284586991.md)
*2026-04-29T13:43:06.000Z*
> MICROPORT announced that its 40.32% subsidiary Endovastec's first-quarter report showed an operating income of 370 milli

### [MicroPort Medical: Endovastec's net profit attributable to shareholders in the first quarter was 155 million yuan, an increase of 19.44% year-on-year](https://longbridge.com/en/news/284549042.md)
*2026-04-29T10:42:04.000Z*
> MicroPort Medical released its Q1 2026 performance, with Shanghai MicroPort Endovastec Medical Technology (Group) Co., L

### [RIMAG GROUP discounts 19% to increase its stake in Yinghe Medical to 25.36%, with a transaction price of 353 million yuan](https://longbridge.com/en/news/284134203.md)
*2026-04-27T01:15:21.000Z*
> RIMAG GROUP announced that it has reached an agreement with two sellers to place shares to increase its stake in Yinghe 

### [MICROPORT: GloMatrix platform deepens with new surgical robot engine | Peng Weixin](https://longbridge.com/en/news/283589323.md)
*2026-04-22T03:00:54.000Z*
> MicroPort is gradually transforming into a diversified platform enterprise in the medical device industry, covering mult

### [MicroPulse "AI + First Stock in Full Disease Management": AI Business Drives Rapid Business Growth](https://longbridge.com/en/news/283431087.md)
*2026-04-21T02:58:42.000Z*
> Weimai Company submitted its prospectus to the Hong Kong Stock Exchange on April 20, 2026, planning to list on the main